Search Details

Word: followers (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...political issues; many more leave Harvard in order to help ourselves. Still, there is an "out" in the inscription for those who will be leaving Harvard this spring not primarily to serve their country or kind, but primarily to make money or have fun or simply be themselves and follow their passion. The inscription, recall, says "Depart to better serve thy country and thy kind"--better than what? Better, it seems logical to presume, than we could before entering the Yard in the first place...

Author: NO WRITER ATTRIBUTED | Title: Enter to Grow in Wisdom | 4/7/1999 | See Source »

...traditional medical school has students spend two years in lecture courses and then two years in clinical training--during which students follow doctors in area "teaching hospitals...

Author: By Erica B. Levy, CONTRIBUTING WRITER | Title: HMS's 'New Pathway' Curriculum Copied at Other Schools | 4/6/1999 | See Source »

...traditional medical school has students spend two years in lecture courses and then two years in clinical training during which students follow doctors in area "teaching hospitals...

Author: By Erica B. Levy, CONTRIBUTING WRITER | Title: Medical School's 'New Pathway' Curriculum Copied at other Schools | 4/6/1999 | See Source »

...actress on? If you're Natasha Richardson, scion of one of Britain's most famous acting families (daughter of Vanessa Redgrave) and trying to carve your own niche on the stage, playing Sally Bowles in a radically revamped version of Cabaret is one sure way. Deciding how to follow up that Tony-winning turn, however, is a tougher call. Richardson twice turned down an offer to join the four-person Broadway cast of Patrick Marber's hit London play Closer. Asked a third time, she thought it over for a weekend and agreed--not because the role promised an acting...

Author: /time Magazine | Title: Theater: Sex in the Trauma Ward | 4/5/1999 | See Source »

...clearly wasn't enough. Though the panel decided to keep Rezulin on the market, its thumbs-up came with a warning to the FDA to limit the drug's use to patients who are failing other treatments. And the ruling made it clear, implicitly at least, that without adequate follow-up, the agency's streamlined approval process could be a fast track to disaster...

Author: /time Magazine | Title: Close Call for a Diabetes Drug | 4/5/1999 | See Source »

Previous | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | Next